Effer-KOrange (Nomax Inc.)


Welcome to the PulseAid listing for the Effer-K drug offered from Nomax Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Nomax Inc.
NON-PROPRIETARY NAME: POTASSIUM BICARBONATE
SUBSTANCE NAME: POTASSIUM BICARBONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, EFFERVESCENT
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2013-01-30
END MARKETING DATE: 0000-00-00


Effer-K Orange HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEffer-K Orange from Nomax Inc.
LABELER NAME: Nomax Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 977.5(mg/1)
START MARKETING DATE: 2013-01-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51801-001_63ede6be-645a-4386-a575-47a4d5469a54
PRODUCT NDC: 51801-001
APPLICATION NUMBER:

Other POTASSIUM BICARBONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthK-Vescent
Major PharmaceuticalsK-Vescent
Nomax Inc.Effer-K
Qualitest PharmaceuticalsK-EFFERVESCENT
Sandoz Inc.KLOR-CON/EF
Tower Laboratories LtdTowerX Effervescent Potassium